| Literature DB >> 19374582 |
Christoph K Naber1, Larry M Baddour, Evangelos J Giamarellos-Bourboulis, Ian M Gould, Mathias Herrmann, Bruno Hoen, Adolf W Karchmer, Yoshio Kobayashi, Roman S Kozlov, Daniel Lew, José M Miró, Robert C Moellering, Philippe Moreillon, Georg Peters, Ethan Rubinstein, Harald Seifert, G Ralph Corey.
Abstract
The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus, highlights the critical need for a consistent approach to therapy. However, there is currently no international consensus on the diagnosis and management of gram-positive BSIs. The Clinical Consensus Conference on Gram-Positive Bloodstream Infections was convened as a session at the 9th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections held in 2007. Participants discussed various aspects of the practical treatment of patients who present with gram-positive BSI, including therapeutic options for patients with BSIs of undefined origin, the selection of appropriate empirical therapy, and treatment of complicated and uncomplicated BSIs. The opinions of participants about these key issues are reflected in this article.Entities:
Mesh:
Year: 2009 PMID: 19374582 DOI: 10.1086/598185
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079